| Extrapulmonary Neuroendocrine Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived83 of 83show fewer |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal antibody 23 trials (13 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 17 trials (12 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Oxodotreotideother 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daromun 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rovalpituzumab Tesirineadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |